Vitamins, homocysteine and cardiovascular risk

Cardiovascular Drugs and Therapy

Volumn 16, Issue 5, 2002, Pages 383-389

  Graham, Ian M ^a,b,c   O'Callaghan, Patrick ^c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

B vitamins; Cardiovascular risk; Homocysteine; Ischaemic heart disease

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

AMINO ACID BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; HEREDITY; HUMAN; ISCHEMIC HEART DISEASE; METABOLISM; NUTRITION; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; VASCULAR DISEASE; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS; FOLIC ACID; HOMOCYSTEINE; HUMANS; RISK FACTORS; VITAMIN B 12; VITAMIN B 6; VITAMINS;

EID: 0036999173     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022126100625     Document Type: Article

References (44)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997;349:1269-1276.
2. Jacobsen DW. Biochemistry and metabolism. In: Robinson K, ed. Homocysteine and Vascular Disease, The Netherlands: Kluwer Academic Publishers, 2000:15-39.
3. Selhub J, Miller JW. The pathogenesis of homocysteinaemia: Interruption of the coordinate regulation by S-adenosyl methionine of remethylation and transsulphuration of homocysteine. Am J Clin Nutr 1992;55:131-138.
4. Glade MJ. Conference review: Workshop on folate, B12 and choline. Nutrition 1999;15:92-96.
5. Bailey LB. Folate requirements and dietary recommendations. In: Bailey LB, ed. Folate in Health and Disease, Marcel Dekker Inc., 1995:123-151.
6. Committee on Medical Aspects of Food and Nutrition Policy. Report of the Committee on Medical Aspects of Food and Nutrition Policy. No. 50. Folicacid and the prevention of disease. London, UK: the Stationary Office, 2000.
7. Department of Health and Social Security. Recommended daily amounts of food energy and nutrients for groups of people in the United Kingdom. Report on Health and Social Subjects 15. London: HMSO, 1979.
8. Commission of the European Community. Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food (31st series). Luxembourg: Office for Official Publications of the European Communities, 1993.
9. Institute of Medicine. A report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its panel on folate, other B-vitamins, and choline and Subcommittee on Upper Reference Levels of Nutrients (pre-publication copy). Washington, DC: National Academy Press, 1998.
10. Nutrition Coordinating Center. Food Database Version 5A: Nutrient Data Base Version 20. Minneapolis, MN: University of Minneosota, 1991.
11. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr 1989;50:508-516.
12. Wilson PW, Jacques PF. Epidemiology of homocysteine levels and relation to vitamins. In: Robinson K, ed. Homocysteine and Vascular Disease. The Netherlands: Kluwer Academic Publishers, 2000:85-95.
13. Ministery of Agriculture, Fisheries and Food. National Food Survey 1998. London: TSO, 1999.
14. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
15. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999;131:331-339.
16. Refsum H, Ueland PM, NygaÊrd O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
17. Gerhard GT, Duell PB. Homocysteine and atherosclerosis. Curr Opin Lipidol 1999;10:417-428.
18. Guthikonda S, Haynes WG. Homocysteine as a novel risk factor for atherosclerosis. Curr Opin Cardiol 1999;14:283-291.
19. Clarke R. Overview. In: Homocysteine and Cardiovascular Disease. J Cardiovasc Risk 1998;5:213-215.
20. Wilcken DEL. Novel risk factors for vascular disease: The homocysteine hypothesis of cardiovascular disease. J Cardiovasc Risk 1998;5:217-221.
21. Scott JM, Weir DG. Folic acid, homocysteine and one-carbon metabolism: A review of the essential biochemistry. J Cardiovasc Risk 1998;5:223-227.
22. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: Systematic review of published epidemiological studies. J Cardiovasc Risk 1998;5:229-232.
23. Meleady RA, Graham IM. Homocysteine and vascular disease: Nature or nurture? J Cardiovasc Risk 1998;5:233-237.
24. Domagata TB, Undas A, Libura M, Szczeklik A. Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk 1998;5:239-247.
25. Clarke R, Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk 1998;5:249-255.
26. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354:407-413.
27. Eikelboom JW, Lonn E, Genest J, Jr, et al. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-375.
28. Robinson K. Homocysteine, B vitamins and risk of cardiovascular disease. Heart 2000;83:127-130.
29. Duall PB, Malinow MR. Homocysteine as a risk factor for coronary artery disease. In: Robinson K, ed. Homocysteine and Vascular Disease. The Netheralnds: Kluwer Academic Publishers, 2000:173-202.
30. Graham IM, O'Callaghan P. The role of folic acid in the prevention of cardiovascular disease. Curr Opin Lipidol 2000;11:577-587.
31. Bostom AG, Silbershatz H, Rosenberg IH, et al. Non fasting plasmahomocysteine levels and all-cause and cardiovascular mortality in elderly Framingham men and women. Arch Intern Med 1999;199:1077-1080.
32. Kark JD, Selhub J, Adler B, et al. Non fasting plasma homocysteine level and mortality in middle aged and elderly men and women in Jerusalem. Ann Intern Med 1999;131:321-330.
33. Boushey CJ, Shirley RD, Beresford AA, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. JAMA 1995;274:1049-1057.
34. Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischaemic heart disease: Results of a prospective study with implications regarding prevention. Arch Intern Med 1998;158:862-867.
35. Graham IM. Homocysteine as a risk factor for cardiovascular disease. Trends Cardiovasc Med 1991;1:244-249.
36. Dudman NPB. An alternative view of homocysteine. Lancet 1999;354:2072-2074.
37. Bolander-Gouaille C. Focus on Homocysteine. Springer, 1999.
38. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Project. JAMA 1997;27:1775-1781.
39. Verhoef P, Meleady R, Daly LE, et al., and the European COMAC Group. Homocysteine, vitamin status and risk of vascular disease. Effects of gender menopausal status. Eur Heart J 1999;9:1234-1244.
40. Robinson K, Arheart K, Refsum H, et al. Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998;97:437-443.
41. Clarke R, Frost C, Leroy V, Collins R. Homocysteine lowering trialists collaboration. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. Br Med J 1998;316:894-898.
42. Malinow MR, Bostom AB, Grauss RM. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-182.
43. Brouwer IA, van Dusseldrop M, West CE, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr 1999;129:1135-1139.
44. Brouwer IA, van Dusseldrop M, Thomas CMG, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: A randomised trial. Am J Clin Nutr 1999;69:99-104.